Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01868451
Brief Title: Brentuximab Vedotin Combined With AVD Chemotherapy in Patients With Newly Diagnosed Early Stage, Unfavorable Risk Hodgkin Lymphoma

First Submitted : May 30, 2013
First Submitted that Met QC Criteria : May 30, 2013
First Posted : June 4, 2013 (Estimate)

Last Update Submitted that Met QC Criteria : July 28, 2020
Last Update Posted : July 29, 2020